Target-Based Anticancer Indole Derivatives for the Development of Anti-Glioblastoma Agents

Glioblastoma (GBM) is the most aggressive and frequent primary brain tumor, with a poor prognosis and the highest mortality rate. Currently, GBM therapy consists of surgical resection of the tumor, radiotherapy, and adjuvant chemotherapy with temozolomide. Consistently, there are poor treatment opti...

詳細記述

書誌詳細

主要な著者:	Silvia Salerno, Elisabetta Barresi, Emma Baglini, Valeria Poggetti, Federico Da Settimo, Sabrina Taliani
フォーマット:	Artigo
言語:	Inglês
出版事項:	MDPI AG 2023-03-01
シリーズ:	Molecules
主題:	indole brain tumor glioblastoma heterocyclic chemistry
オンライン･アクセス:	https://www.mdpi.com/1420-3049/28/6/2587
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!